Craig Meagher

751 total citations
17 papers, 629 citations indexed

About

Craig Meagher is a scholar working on Immunology, Genetics and Surgery. According to data from OpenAlex, Craig Meagher has authored 17 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Genetics and 5 papers in Surgery. Recurrent topics in Craig Meagher's work include Diabetes and associated disorders (8 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Craig Meagher is often cited by papers focused on Diabetes and associated disorders (8 papers), Immune Cell Function and Interaction (7 papers) and T-cell and B-cell Immunology (6 papers). Craig Meagher collaborates with scholars based in Canada, United States and United Kingdom. Craig Meagher's co-authors include Terry L. Delovitch, Marsha Grattan, Qing‐Sheng Mi, Guillermo Arreaza, Mark J. Cameron, Konstantin V. Salojin, Jian Zhang, Shayan Sharif, Donald N. Cook and Robert M. Strieter and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Craig Meagher

17 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Craig Meagher Canada 13 370 236 162 159 113 17 629
Lars Hornum Denmark 12 308 0.8× 208 0.9× 122 0.8× 133 0.8× 35 0.3× 27 546
Eva Dahlén Sweden 7 407 1.1× 254 1.1× 140 0.9× 112 0.7× 199 1.8× 10 656
Zuoan Yi United States 18 671 1.8× 148 0.6× 122 0.8× 192 1.2× 110 1.0× 24 858
Huilian Qin Canada 11 434 1.2× 344 1.5× 176 1.1× 101 0.6× 121 1.1× 13 702
Kim Dawe United Kingdom 11 403 1.1× 321 1.4× 144 0.9× 88 0.6× 39 0.3× 13 668
Anil K. Panigrahi United States 17 255 0.7× 204 0.9× 57 0.4× 446 2.8× 55 0.5× 29 849
Jeffery H. Carpenter United States 7 351 0.9× 77 0.3× 71 0.4× 316 2.0× 147 1.3× 8 662
Jon Kuniyoshi United States 10 486 1.3× 126 0.5× 139 0.9× 335 2.1× 201 1.8× 11 922
Francisco Victorino United States 14 348 0.9× 99 0.4× 120 0.7× 110 0.7× 72 0.6× 19 541
Jingbo Yan China 8 119 0.3× 81 0.3× 186 1.1× 239 1.5× 136 1.2× 11 500

Countries citing papers authored by Craig Meagher

Since Specialization
Citations

This map shows the geographic impact of Craig Meagher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig Meagher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig Meagher more than expected).

Fields of papers citing papers by Craig Meagher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig Meagher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig Meagher. The network helps show where Craig Meagher may publish in the future.

Co-authorship network of co-authors of Craig Meagher

This figure shows the co-authorship network connecting the top 25 collaborators of Craig Meagher. A scholar is included among the top collaborators of Craig Meagher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig Meagher. Craig Meagher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhu, Min, Kara Olson, Jessica R. Kirshner, et al.. (2022). Translational findings for odronextamab: From preclinical research to a first‐in‐human study in patients with CD20+ B‐cell malignancies. Clinical and Translational Science. 15(4). 954–966. 11 indexed citations
2.
Beilke, Joshua, et al.. (2012). NK Cells Are Not Required for Spontaneous Autoimmune Diabetes in NOD Mice. PLoS ONE. 7(4). e36011–e36011. 17 indexed citations
3.
DeVoss, Jason, Yafei Hou, Kellsey Johannes, et al.. (2010). An Autoimmune Response to Odorant Binding Protein 1a Is Associated with Dry Eye in the Aire-Deficient Mouse. The Journal of Immunology. 184(8). 4236–4246. 38 indexed citations
4.
Meagher, Craig, Guillermo Arreaza, Qing‐Sheng Mi, et al.. (2010). Neutralization of Interleukin-16 Protects Nonobese Diabetic Mice From Autoimmune Type 1 Diabetes by a CCL4-Dependent Mechanism. Diabetes. 59(11). 2862–2871. 32 indexed citations
5.
DeVoss, Jason, Anthony K. Shum, Craig Meagher, et al.. (2008). Cellular Control of Autoimmunity in the Aire-Deficient Mouse Model of Sjogren’s Syndrome. Investigative Ophthalmology & Visual Science. 49(13). 190–190. 2 indexed citations
6.
Meagher, Craig, Qizhi Tang, Brian T. Fife, et al.. (2008). Spontaneous Development of a Pancreatic Exocrine Disease in CD28-Deficient NOD Mice. The Journal of Immunology. 180(12). 7793–7803. 38 indexed citations
7.
Meagher, Craig, Guillermo Arreaza, Andrew Peters, et al.. (2007). CCL4 Protects From Type 1 Diabetes by Altering Islet β-Cell–Targeted Inflammatory Responses. Diabetes. 56(3). 809–817. 28 indexed citations
8.
Meagher, Craig, Shayan Sharif, Shabbir Hussain, et al.. (2003). Cytokines and Chemokines in the Pathogenesis of Murine Type 1 Diabetes. Advances in experimental medicine and biology. 520. 133–158. 18 indexed citations
9.
Arreaza, Guillermo, Konstantin V. Salojin, Wen Yang, et al.. (2003). Deficient activation and resistance to activation-induced apoptosis of cd8+ t cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clinical Immunology. 107(2). 103–115. 32 indexed citations
10.
Mi, Qing‐Sheng, Dalam Ly, Salah-Eddine Lamhamedi-Cherradi, et al.. (2003). Blockade of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Exacerbates Type 1 Diabetes in NOD Mice. Diabetes. 52(8). 1967–1975. 88 indexed citations
11.
Mi, Qing‐Sheng, Craig Meagher, & Terry L. Delovitch. (2003). CD1d‐Restricted NKT Regulatory Cells: Functional Genomic Analyses Provide New Insights into the Mechanisms of Protection against Type 1 Diabetes. Novartis Foundation symposium. 252. 146–164. 12 indexed citations
12.
Grattan, Marsha, Qing‐Sheng Mi, Craig Meagher, & Terry L. Delovitch. (2002). Congenic Mapping of the Diabetogenic LocusIdd4to a 5.2-cM Region of Chromosome 11 in NOD Mice. Diabetes. 51(1). 215–223. 58 indexed citations
13.
Salojin, Konstantin V., Jian Zhang, Craig Meagher, & Terry L. Delovitch. (2000). ZAP-70 Is Essential for the T Cell Antigen Receptor-induced Plasma Membrane Targeting of SOS and Vav in T Cells. Journal of Biological Chemistry. 275(8). 5966–5975. 37 indexed citations
14.
Zhang, Jian, Jianxin Gao, Qing Shao, et al.. (2000). Regulation of FAS Ligand Expression during Activation-Induced Cell Death in T Cells by p38 Mitogen-Activated Protein Kinase and C-Jun Nh2-Terminal Kinase. The Journal of Experimental Medicine. 191(6). 1017–1030. 80 indexed citations
15.
Cameron, Mark J., Guillermo Arreaza, Marsha Grattan, et al.. (2000). Differential Expression of CC Chemokines and the CCR5 Receptor in the Pancreas Is Associated with Progression to Type I Diabetes. The Journal of Immunology. 165(2). 1102–1110. 126 indexed citations
16.
Cameron, Mark J., Craig Meagher, & Terry L. Delovitch. (1998). Failure in immune regulation begets IDDM in NOD mice. Diabetes/Metabolism Reviews. 14(2). 177–185. 11 indexed citations
17.
Cameron, Mark J., Craig Meagher, & Terry L. Delovitch. (1998). Failure in immune regulation begets IDDM in NOD mice. Diabetes/Metabolism Reviews. 14(2). 177–185. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026